This, combined with the associated concomitant medication use, which impacts both renal function and uric acid [ 36], may further increase hyperuricemia.
Numerous studies have demonstrated that people find following medication regimens problematic, that various lifestyle, psychological and social factors are implicated in this, that inappropriate medication use adversely impacts on patients' health outcomes and hospital admissions, and the costs of this to health care systems are highly significant [ 1].
To explore if medication use may be impacting on our findings, respective associations were explored between daytime napping and type of medication used.
Since these studies were not designed to measure emergent TD, limited historical data were available regarding prior medication use that could impact patients' susceptibility to drug-induced movement disorders.
While most studies adjusted for some clinical characteristics, only some controlled for socioeconomic factors that could also have impacted medication use.
Their comments were grouped analytically into four domains: ADHD Medical History (diagnosis, symptoms and medication use), Life Experience, Daily Life Impacts of ADHD and Psychological and Social Impacts of ADHD.
It is not clear what impact medication use had on mood outcomes, but it appears unlikely that the clinically and statistically significant improvement observed in the experimental group was due to greater overall antidepressant use in this group.
Because many individuals with psychiatric disorder never receive care from specialist services, these studies are limited to participants who were at the most extreme end of a continuum of distress present in the population, and results were also potentially confounded by medication use and other iatrogenic impacts.
The impact of medication use was therefore explored in this study by looking at the impact of different types of medication on napping behaviour, however more detailed investigation on the effect of varying dosages and brands of medication is warranted.
After initiating drug therapy, safety assessments at regular intervals are useful to observe the ongoing impact of medication use (Table 3).
